Broshy Eran insider trades
Broshy Eran has filed 13 Form 4s with the SEC that we hold, for Theravance Biopharma, Inc. (TBPH) (Director) and Certara, Inc. (CERT) (Director). Across all of them we count 2 purchases worth $79.1K and 6 sales worth $1.9M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($1.9M). The largest single trade was a sale of 29,500 shares of Theravance Biopharma, Inc. worth $545.8K, dated 2025-11-11. The first filing on our record is dated 2022-04-28 and the latest 2026-05-15.
Theravance Biopharma, Inc. (TBPH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2025-11-11 | S, sale reported on Form 4 | 14,000 | $259.0K | 2025-11-14 |
| 2025-11-11 | S, sale reported on Form 4 | 15,500 | $286.8K | 2025-11-14 |
| 2025-11-11 | S, sale reported on Form 4 | 15,500 | $263.5K | 2025-11-14 |
| 2025-11-11 | S, sale reported on Form 4 | 29,500 | $545.8K | 2025-11-13 |
| 2025-11-26 | S, sale reported on Form 4 | 15,501 | $310.0K | 2025-12-01 |
| 2025-11-26 | S, sale reported on Form 4 | 14,000 | $280.0K | 2025-12-01 |
Certara, Inc. (CERT)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2023-08-21 | P, purchase reported on Form 4 | 193 | $3.1K | 2023-08-23 |
| 2023-08-22 | P, purchase reported on Form 4 | 4,807 | $76.0K | 2023-08-23 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1256230) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms